Reagents and treatment methods for autoimmune diseases

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/13 (2006.01) A61K 39/395 (2006.01) C07K 16/28 (2006.01) C07K 14/705 (2006.01)

Patent

CA 2476776

The invention concerns treatment methods using anti-CD22 monoclonal antibodies with unique physiologic properties. In particular, the invention concerns methods for the treatment of B-cell malignancies and autoimmune diseases by administering an effective amount of a blocking anti-CD22 monoclonal antibody specifically binding to the first two Ig-like domains, or to an epitope within the first two Ig-like domains of native human CD22 (hCD22).

L'invention concerne des méthodes thérapeutiques utilisant des anticorps monoclonaux anti-CD22 faisant preuve de propriétés physiologiques uniques. L'invention concerne plus particulièrement des méthodes thérapeutiques de tumeurs malignes associées aux lymphocytes B et de maladies auto-immunes par administration d'une quantité efficace d'un anticorps monoclonal anti-CD22 de blocage spécifiquement lié aux deux premiers domaines de type Ig ou à un épitope se trouvant dans les deux premiers domaines de type Ig de CD22 humain natif (hCD22).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Reagents and treatment methods for autoimmune diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Reagents and treatment methods for autoimmune diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reagents and treatment methods for autoimmune diseases will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1627782

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.